List of works - Kenichi Suda

A true Brunner's gland adenoma

scientific article published on 07 February 2007

Analysis of ERBB4 mutations and expression in japanese patients with lung cancer.

scientific article

CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation

scientific article

Clinical, Pathological, and Molecular Features of Lung Adenocarcinomas with AXL Expression

scientific article

Collateral chemoresistance to anti-microtubule agents in a lung cancer cell line with acquired resistance to erlotinib

scientific article published on 14 April 2015

Combined therapy with mutant-selective EGFR inhibitor and Met kinase inhibitor for overcoming erlotinib resistance in EGFR-mutant lung cancer.

scientific article

Conversion from the "oncogene addiction" to "drug addiction" by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutation

scientific article

Development of personalized treatments in lung cancer: focusing on the EGFR mutations and beyond.

scientific article published on 14 August 2013

EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib or Neratinib as Compared with First- or Third-Generation TKIs

scientific article

EGFR T790M mutation: a double role in lung cancer cell survival?

scientific article published on January 2009

Efficacy of erlotinib for brain and leptomeningeal metastases in patients with lung adenocarcinoma who showed initial good response to gefitinib

scientific article published in November 2009

Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib

scientific article published on July 2011

Functional Analyses of Mutations in Receptor Tyrosine Kinase Genes in Non-Small Cell Lung Cancer: Double-Edged Sword of DDR2.

scientific article published on 29 January 2016

Heterogeneity in Tumors and Resistance to EGFR TKI Therapy-Letter

scientific article published on 2 May 2016

Heterogeneity in resistance mechanisms causes shorter duration of epidermal growth factor receptor kinase inhibitor treatment in lung cancer.

scientific article

Heterogeneity of EGFR Aberrations and Correlation with Histological Structures: Analyses of Therapy-Naive Isogenic Lung Cancer Lesions with EGFR Mutation

scientific article published on 30 May 2016

Highly sensitive detection of EGFR T790M mutation using colony hybridization predicts favorable prognosis of patients with lung cancer harboring activating EGFR mutation

scientific article published in November 2012

Hsp90 Inhibition Overcomes HGF-Triggering Resistance to EGFR-TKIs in EGFR-Mutant Lung Cancer by Decreasing Client Protein Expression and Angiogenesis

scientific article published on 01 July 2012

Impact of age on epidermal growth factor receptor mutation in lung cancer.

scientific article

Impact of bevacizumab in combination with erlotinib on EGFR-mutated non-small cell lung cancer xenograft models with T790M mutation or MET amplification.

scientific article published on 15 September 2015

Increased EGFR Phosphorylation Correlates with Higher Programmed Death Ligand-1 Expression: Analysis of TKI-Resistant Lung Cancer Cell Lines

scientific article published on 8 October 2017

Lung cancers unrelated to smoking: characterized by single oncogene addiction?

scientific article

Molecular Factors Associated with Pemetrexed Sensitivity According to Histological Type in Non-small Cell Lung Cancer

scientific article

New and emerging targeted treatments in advanced non-small-cell lung cancer.

scientific article published on September 2016

Oncogene swap as a novel mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor in lung cancer

scientific article published on 4 February 2016

Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status

scientific article

Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal from the Bench

scientific article published on 15 September 2016

Prognosis and segment-specific nodal spread of primary lung cancer in the right lower lobe.

scientific article

Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers

scientific article published on 25 February 2011

Prognostic and therapeutic implications of aromatase expression in lung adenocarcinomas with EGFR mutations

scientific article published on 6 May 2014

Prognostic impact of pleural lavage cytology in patients with primary lung cancer

scientific article published on 24 October 2016

Prognostic implication of predominant histologic subtypes of lymph node metastases in surgically resected lung adenocarcinoma

scientific article

Progression after spontaneous regression in lung large cell neuroendocrine carcinoma: Report of a curative resection

scientific article

Racial differences in lung cancer genetics

scientific article

Recent evidence, advances, and current practices in surgical treatment of lung cancer.

scientific article

Reciprocal and complementary role of MET amplification and EGFR T790M mutation in acquired resistance to kinase inhibitors in lung cancer

scientific article published on 9 November 2010

Role of EGFR mutations in lung cancers: prognosis and tumor chemosensitivity.

scientific article published on 17 May 2015

Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer.

scientific article

Solitary pulmonary metastasis from lung cancer harboring EML4-ALK after a 15-year disease-free interval.

scientific article

Solitary pulmonary metastasis from malignant melanoma of the bulbar conjunctiva presenting as a pulmonary ground glass nodule: Report of a case

scientific article published on 7 January 2015

Successes and limitations of targeted cancer therapy in lung cancer

scientific article published on 17 February 2014

Surgery for NSCLC in the era of personalized medicine ⬇️

scientific article published on February 26, 2013

The insulin-like growth factor 1 receptor causes acquired resistance to erlotinib in lung cancer cells with the wild-type epidermal growth factor receptor

scientific article published on 4 February 2014

Unintentional Weakness of Cancers: The MEK–ERK Pathway as a Double-Edged Sword ⬇️

scientific article published on July 30, 2013

[Acquired resistance mechanisms to EGFR-TKIs in EGFR mutated lung cancers].

scientific article published in November 2012

List of works by Kenichi Suda

A true Brunner's gland adenoma

Analysis of ERBB4 mutations and expression in japanese patients with lung cancer.

CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation

Clinical, Pathological, and Molecular Features of Lung Adenocarcinomas with AXL Expression

Collateral chemoresistance to anti-microtubule agents in a lung cancer cell line with acquired resistance to erlotinib

Combined therapy with mutant-selective EGFR inhibitor and Met kinase inhibitor for overcoming erlotinib resistance in EGFR-mutant lung cancer.

Conversion from the "oncogene addiction" to "drug addiction" by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutation

Development of personalized treatments in lung cancer: focusing on the EGFR mutations and beyond.

EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib or Neratinib as Compared with First- or Third-Generation TKIs

EGFR T790M mutation: a double role in lung cancer cell survival?

Efficacy of erlotinib for brain and leptomeningeal metastases in patients with lung adenocarcinoma who showed initial good response to gefitinib

Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib

Functional Analyses of Mutations in Receptor Tyrosine Kinase Genes in Non-Small Cell Lung Cancer: Double-Edged Sword of DDR2.

Heterogeneity in Tumors and Resistance to EGFR TKI Therapy-Letter

Heterogeneity in resistance mechanisms causes shorter duration of epidermal growth factor receptor kinase inhibitor treatment in lung cancer.

Heterogeneity of EGFR Aberrations and Correlation with Histological Structures: Analyses of Therapy-Naive Isogenic Lung Cancer Lesions with EGFR Mutation

Highly sensitive detection of EGFR T790M mutation using colony hybridization predicts favorable prognosis of patients with lung cancer harboring activating EGFR mutation

Hsp90 Inhibition Overcomes HGF-Triggering Resistance to EGFR-TKIs in EGFR-Mutant Lung Cancer by Decreasing Client Protein Expression and Angiogenesis

Impact of age on epidermal growth factor receptor mutation in lung cancer.

Impact of bevacizumab in combination with erlotinib on EGFR-mutated non-small cell lung cancer xenograft models with T790M mutation or MET amplification.

Increased EGFR Phosphorylation Correlates with Higher Programmed Death Ligand-1 Expression: Analysis of TKI-Resistant Lung Cancer Cell Lines

Lung cancers unrelated to smoking: characterized by single oncogene addiction?

Molecular Factors Associated with Pemetrexed Sensitivity According to Histological Type in Non-small Cell Lung Cancer

New and emerging targeted treatments in advanced non-small-cell lung cancer.

Oncogene swap as a novel mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor in lung cancer

Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status

Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal from the Bench

Prognosis and segment-specific nodal spread of primary lung cancer in the right lower lobe.

Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers

Prognostic and therapeutic implications of aromatase expression in lung adenocarcinomas with EGFR mutations

Prognostic impact of pleural lavage cytology in patients with primary lung cancer

Prognostic implication of predominant histologic subtypes of lymph node metastases in surgically resected lung adenocarcinoma

Progression after spontaneous regression in lung large cell neuroendocrine carcinoma: Report of a curative resection

Racial differences in lung cancer genetics

Recent evidence, advances, and current practices in surgical treatment of lung cancer.

Reciprocal and complementary role of MET amplification and EGFR T790M mutation in acquired resistance to kinase inhibitors in lung cancer

Role of EGFR mutations in lung cancers: prognosis and tumor chemosensitivity.

Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer.

Solitary pulmonary metastasis from lung cancer harboring EML4-ALK after a 15-year disease-free interval.

Solitary pulmonary metastasis from malignant melanoma of the bulbar conjunctiva presenting as a pulmonary ground glass nodule: Report of a case

Successes and limitations of targeted cancer therapy in lung cancer

Surgery for NSCLC in the era of personalized medicine ⬇️

The insulin-like growth factor 1 receptor causes acquired resistance to erlotinib in lung cancer cells with the wild-type epidermal growth factor receptor

Unintentional Weakness of Cancers: The MEK–ERK Pathway as a Double-Edged Sword ⬇️

[Acquired resistance mechanisms to EGFR-TKIs in EGFR mutated lung cancers].